135 related articles for article (PubMed ID: 17331554)
1. Murine alveolar macrophages limit replication of vaccinia virus.
Rivera R; Hutchens M; Luker KE; Sonstein J; Curtis JL; Luker GD
Virology; 2007 Jun; 363(1):48-58. PubMed ID: 17331554
[TBL] [Abstract][Full Text] [Related]
2. Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread.
Luker KE; Hutchens M; Schultz T; Pekosz A; Luker GD
Virology; 2005 Oct; 341(2):284-300. PubMed ID: 16095645
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection.
Hutchens MA; Luker KE; Sonstein J; Núñez G; Curtis JL; Luker GD
PLoS Pathog; 2008 Sep; 4(9):e1000153. PubMed ID: 18802464
[TBL] [Abstract][Full Text] [Related]
4. TLR3 increases disease morbidity and mortality from vaccinia infection.
Hutchens M; Luker KE; Sottile P; Sonstein J; Lukacs NW; Núñez G; Curtis JL; Luker GD
J Immunol; 2008 Jan; 180(1):483-91. PubMed ID: 18097050
[TBL] [Abstract][Full Text] [Related]
5. Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.
Byrd D; Shepherd N; Lan J; Hu N; Amet T; Yang K; Desai M; Yu Q
J Virol; 2014 Jun; 88(12):6819-31. PubMed ID: 24696488
[TBL] [Abstract][Full Text] [Related]
6. Measurements of vaccinia virus dissemination using whole body imaging: approaches for predicting of lethality in challenge models and testing of vaccines and antiviral treatments.
Zaitseva M; Kapnick S; Golding H
Methods Mol Biol; 2012; 890():161-76. PubMed ID: 22688767
[TBL] [Abstract][Full Text] [Related]
7. Allergic airway disease in mice alters T and B cell responses during an acute respiratory poxvirus infection.
Walline CC; Sehra S; Fisher AJ; Guindon LM; Kratzke IM; Montgomery JB; Lipking KP; Glosson NL; Benson HL; Sandusky GE; Wilkes DS; Brutkiewicz RR; Kaplan MH; Blum JS
PLoS One; 2013; 8(4):e62222. PubMed ID: 23620814
[TBL] [Abstract][Full Text] [Related]
8. A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection.
Reading PC; Smith GL
J Gen Virol; 2003 Aug; 84(Pt 8):1973-1983. PubMed ID: 12867627
[TBL] [Abstract][Full Text] [Related]
9. Bi-Reporter Vaccinia Virus for Tracking Viral Infections
Chiem K; Lorenzo MM; Rangel-Moreno J; Garcia-Hernandez ML; Park JG; Nogales A; Blasco R; Martínez-Sobrido L
Microbiol Spectr; 2021 Dec; 9(3):e0160121. PubMed ID: 34817228
[TBL] [Abstract][Full Text] [Related]
10. Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage.
Lehmann MH; Price PJ; Brandmüller C; Sutter G
Virol J; 2015 Feb; 12():21. PubMed ID: 25889495
[TBL] [Abstract][Full Text] [Related]
11. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract.
Worgall S; Leopold PL; Wolff G; Ferris B; Van Roijen N; Crystal RG
Hum Gene Ther; 1997 Sep; 8(14):1675-84. PubMed ID: 9322870
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
[TBL] [Abstract][Full Text] [Related]
13. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
[TBL] [Abstract][Full Text] [Related]
14. Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions.
Ramírez JC; Tapia E; Esteban M
J Gen Virol; 2002 May; 83(Pt 5):1059-1067. PubMed ID: 11961260
[TBL] [Abstract][Full Text] [Related]
15. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.
Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA
Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus induces rapid necrosis in keratinocytes by a STAT3-dependent mechanism.
He Y; Fisher R; Chowdhury S; Sultana I; Pereira CP; Bray M; Reed JL
PLoS One; 2014; 9(11):e113690. PubMed ID: 25419841
[TBL] [Abstract][Full Text] [Related]
17. The role of alveolar macrophages in inhalation infection of rabbits with vaccinia virus. I. Experiments with large doses of virus.
Danes L; Benda R; Kruml J; Jelínková A
Acta Virol; 1969 Nov; 13(6):521-6. PubMed ID: 4391719
[No Abstract] [Full Text] [Related]
18. Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV).
Benoit A; Huang Y; Proctor J; Rowden G; Anderson R
Clin Exp Immunol; 2006 Jul; 145(1):147-54. PubMed ID: 16792685
[TBL] [Abstract][Full Text] [Related]
19. Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread.
Cush SS; Reynoso GV; Kamenyeva O; Bennink JR; Yewdell JW; Hickman HD
PLoS Pathog; 2016 Mar; 12(3):e1005493. PubMed ID: 26991092
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus triggers synthesis of IL-6 in BALB/c mouse alveolar macrophages in the absence of virus replication.
Stadnyk AW; Gillan TL; Anderson R
Cell Immunol; 1997 Mar; 176(2):122-6. PubMed ID: 9073384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
